319 related articles for article (PubMed ID: 15500122)
1. [Podocyte injury and glomerular sclerosis].
Matsusaka T
Nihon Rinsho; 2004 Oct; 62(10):1805-10. PubMed ID: 15500122
[TBL] [Abstract][Full Text] [Related]
2. Targeting podocyte-associated diseases.
Leeuwis JW; Nguyen TQ; Dendooven A; Kok RJ; Goldschmeding R
Adv Drug Deliv Rev; 2010 Nov; 62(14):1325-36. PubMed ID: 20828590
[TBL] [Abstract][Full Text] [Related]
3. The role of podocytes in glomerular pathobiology.
Asanuma K; Mundel P
Clin Exp Nephrol; 2003 Dec; 7(4):255-9. PubMed ID: 14712353
[TBL] [Abstract][Full Text] [Related]
4. HIV-associated nephropathy: experimental models.
Avila-Casado C; Fortoul TI; Chugh SS
Contrib Nephrol; 2011; 169():270-285. PubMed ID: 21252526
[TBL] [Abstract][Full Text] [Related]
5. Permanent genetic tagging of podocytes: fate of injured podocytes in a mouse model of glomerular sclerosis.
Asano T; Niimura F; Pastan I; Fogo AB; Ichikawa I; Matsusaka T
J Am Soc Nephrol; 2005 Aug; 16(8):2257-62. PubMed ID: 15987751
[TBL] [Abstract][Full Text] [Related]
6. Podocytes, parietal cells, and glomerular pathology: the role of cell cycle proteins.
Nagata M; Tomari S; Kanemoto K; Usui J; Lemley KV
Pediatr Nephrol; 2003 Jan; 18(1):3-8. PubMed ID: 12488982
[TBL] [Abstract][Full Text] [Related]
7. Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction.
Wiggins JE; Goyal M; Sanden SK; Wharram BL; Shedden KA; Misek DE; Kuick RD; Wiggins RC
J Am Soc Nephrol; 2005 Oct; 16(10):2953-66. PubMed ID: 16120818
[TBL] [Abstract][Full Text] [Related]
8. Podocyte biology in segmental sclerosis and progressive glomerular injury.
Barisoni L
Adv Chronic Kidney Dis; 2012 Mar; 19(2):76-83. PubMed ID: 22449344
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 genes vpr and nef synergistically damage podocytes, leading to glomerulosclerosis.
Zuo Y; Matsusaka T; Zhong J; Ma J; Ma LJ; Hanna Z; Jolicoeur P; Fogo AB; Ichikawa I
J Am Soc Nephrol; 2006 Oct; 17(10):2832-43. PubMed ID: 16988066
[TBL] [Abstract][Full Text] [Related]
10. Lessons from studies on focal segmental glomerulosclerosis: an important role for parietal epithelial cells?
Smeets B; Dijkman HB; Wetzels JF; Steenbergen EJ
J Pathol; 2006 Nov; 210(3):263-72. PubMed ID: 16924588
[TBL] [Abstract][Full Text] [Related]
11. Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury.
Matsusaka T; Xin J; Niwa S; Kobayashi K; Akatsuka A; Hashizume H; Wang QC; Pastan I; Fogo AB; Ichikawa I
J Am Soc Nephrol; 2005 Apr; 16(4):1013-23. PubMed ID: 15758046
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of CD44-positive glomerular parietal epithelial cells reflects podocyte injury in adriamycin nephropathy.
Okamoto T; Sasaki S; Yamazaki T; Sato Y; Ito H; Ariga T
Nephron Exp Nephrol; 2013; 124(3-4):11-8. PubMed ID: 24401840
[TBL] [Abstract][Full Text] [Related]
13. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of Scarring in Focal Segmental Glomerulosclerosis.
Zhong J; Whitman JB; Yang HC; Fogo AB
J Histochem Cytochem; 2019 Sep; 67(9):623-632. PubMed ID: 31116068
[TBL] [Abstract][Full Text] [Related]
15. Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat.
Fries JW; Sandstrom DJ; Meyer TW; Rennke HG
Lab Invest; 1989 Feb; 60(2):205-18. PubMed ID: 2915515
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of podocyte phenotype in idiopathic collapsing glomerulopathy and HIV-associated nephropathy.
Yang Y; Gubler MC; Beaufils H
Nephron; 2002 Jul; 91(3):416-23. PubMed ID: 12119471
[TBL] [Abstract][Full Text] [Related]
17. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene.
Wharram BL; Goyal M; Wiggins JE; Sanden SK; Hussain S; Filipiak WE; Saunders TL; Dysko RC; Kohno K; Holzman LB; Wiggins RC
J Am Soc Nephrol; 2005 Oct; 16(10):2941-52. PubMed ID: 16107576
[TBL] [Abstract][Full Text] [Related]
18. Animal models of FSGS: lessons for pathogenesis and treatment.
Fogo AB
Semin Nephrol; 2003 Mar; 23(2):161-71. PubMed ID: 12704576
[TBL] [Abstract][Full Text] [Related]
19. Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.
Blanco S; Vaquero M; Gómez-Guerrero C; López D; Egido J; Romero R
Am J Hypertens; 2005 Apr; 18(4 Pt 1):557-65. PubMed ID: 15831368
[TBL] [Abstract][Full Text] [Related]
20. Podocyte detachment and epithelial cell reaction in focal segmental glomerulosclerosis with cellular variants.
Kihara I; Tsuchida S; Yaoita E; Yamamoto T; Hara M; Yanagihara T; Takada T
Kidney Int Suppl; 1997 Dec; 63():S171-6. PubMed ID: 9407451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
